OMX Stockholm 30
2.528,72
PKT
+3,47
PKT
+0,14
%
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.11.12 | Hennes Mauritz (H M, H&M) sell | Société Générale Group S.A. (SG) | |
| 19.11.12 | AstraZeneca hold | Deutsche Bank AG | |
| 16.11.12 | Volvo (B) overweight | Morgan Stanley | |
| 16.11.12 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 15.11.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 14.11.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 09.11.12 | Hennes Mauritz (H M, H&M) neutral | Goldman Sachs Group Inc. | |
| 08.11.12 | SECURITAS neutral | UBS AG | |
| 07.11.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Exane-BNP Paribas SA | |
| 07.11.12 | Ericsson (Telefon L.M.Ericsson) (B) neutral | UBS AG | |
| 07.11.12 | Ericsson (Telefon L.M.Ericsson) (B) hold | Société Générale Group S.A. (SG) | |
| 06.11.12 | Ericsson (Telefon L.M.Ericsson) (B) overweight | J.P. Morgan Cazenove | |
| 05.11.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Cheuvreux SA | |
| 05.11.12 | Sandvik neutral | Nomura | |
| 31.10.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 30.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 30.10.12 | Ericsson (Telefon L.M.Ericsson) (B) kaufen | Independent Research GmbH | |
| 30.10.12 | ABB (Asea Brown Boveri) equal-weight | Morgan Stanley | |
| 30.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 30.10.12 | Ericsson (Telefon L.M.Ericsson) (B) hold | Deutsche Bank AG | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) underperform | Credit Suisse Group | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) outperform | Exane-BNP Paribas SA | |
| 29.10.12 | Hennes Mauritz (H M, H&M) underperform | Credit Suisse Group | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) neutral | UBS AG | |
| 29.10.12 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
| 29.10.12 | Ericsson (Telefon L.M.Ericsson) (B) hold | Société Générale Group S.A. (SG) | |
| 29.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 26.10.12 | Sandvik neutral | Exane-BNP Paribas SA | |
| 26.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 26.10.12 | Sandvik sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 26.10.12 | Skandinaviska Enskilda Banken (SEB) sell | Société Générale Group S.A. (SG) | |
| 26.10.12 | Skandinaviska Enskilda Banken (SEB) buy | UBS AG | |
| 26.10.12 | Skandinaviska Enskilda Banken (SEB) neutral | Exane-BNP Paribas SA | |
| 26.10.12 | Ericsson (Telefon L.M.Ericsson) (B) buy | Sarasin Research | |
| 25.10.12 | Volvo (B) overweight | Morgan Stanley | |
| 25.10.12 | Volvo (B) buy | UBS AG | |
| 25.10.12 | Volvo (B) buy | Deutsche Bank AG | |
| 25.10.12 | SSAB Svenskt Stal equal-weight | Morgan Stanley |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.